GD1a

General | Antibody | Glycoprotein | Glycolipid | Enzyme | Reference

14 reference for EP0056

sort by year ∧ ∨ Reference detail
1 Kotani M, Terashima T, Tai T.
Developmental changes of ganglioside expressions in postnatal rat cerebellar cortex.
Brain Res. 1995 Nov 27;700(1-2):40-58
PMID: 8624728
2 Kawashima I, Nagata I, Tai T.
Immunocytochemical analysis of gangliosides in rat primary cerebellar cultures using specific monoclonal antibodies.
Brain Res. 1996 Sep 2;732(1-2):75-86
PMID: 8891271
3 Kotani M, Kawashima I, Ozawa H, Terashima T, Tai T.
Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies.
Glycobiology. 1993 Apr ;3(2):137-46
PMID: 8490240
4 Ravindranath MH, Muthugounder S, Presser N, Selvan SR, Portoukalian J, Brosman S, Morton DL.
Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer.
Biochem Biophys Res Commun. 2004 Nov 5;324(1):154-65
PMID: 15464996
5 Kotani M, Ozawa H, Kawashima I, Ando S, Tai T.
Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides.
Biochim Biophys Acta. 1992 Jul 21;1117(1):97-103
PMID: 1627599
6 Schnaar RL, Fromholt SE, Gong Y, Vyas AA, Laroy W, Wayman DM, Heffer-Lauc M, Ito H, Ishida H, Kiso M, Griffin JW, Shiekh KA.
Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
Anal Biochem. 2002 Mar 15;302(2):276-84
PMID: 11878808
7 Furukawa K, Yamaguchi H, Oettgen HF, Old LJ, Lloyd KO.
Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
Cancer Res. 1989 Jan 1;49(1):191-6
PMID: 2908845
8 Yamaguchi H, Furukawa K, Fortunato SR, Livingston PO, Lloyd KO, Oettgen HF, Old LJ.
Cell-surface antigens of melanoma recognized by human monoclonal antibodies.
Proc Natl Acad Sci U S A. 1987 Apr ;84(8):2416-20
PMID: 3031684
9 Gong Y, Tagawa Y, Lunn MP, Laroy W, Heffer-Lauc M, Li CY, Griffin JW, Schnaar RL, Sheikh KA.
Localization of major gangliosides in the PNS: implications for immune neuropathies.
Brain. 2002 Nov ;125(Pt 11):2491-506
PMID: 12390975
10 Hildebrandt H.
Antigen binding of antiganglioside antibodies in vitro is strongly influenced by the ganglioside composition of the sample.
FEBS Lett. 1996 Jun 10;388(1):29-33
PMID: 8654583
11 Vinson M, Strijbos PJ, Rowles A, Facci L, Moore SE, Simmons DL, Walsh FS.
Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition.
J Biol Chem. 2001 Jun 8;276(23):20280-5
PMID: 11279053
12 Townson K, Greenshields KN, Veitch J, Nicholl D, Eckhardt M, Galanina O, Bovin N, Samain E, Antoine T, Bundle D, Zhang P, Ling CC, Willison HJ.
Sulfatide binding properties of murine and human antiganglioside antibodies.
Glycobiology. 2007 Nov ;17(11):1156-66
PMID: 17855742
13 Boffey J, Odaka M, Nicoll D, Wagner ER, Townson K, Bowes T, Conner J, Furukawa K, Willison HJ.
Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire.
J Neuroimmunol. 2005 Aug ;165(1-2):92-103
PMID: 15967512
14 Lunn MP, Johnson LA, Fromholt SE, Itonori S, Huang J, Vyas AA, Hildreth JE, Griffin JW, Schnaar RL, Sheikh KA.
High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.
J Neurochem. 2000 Jul ;75(1):404-12
PMID: 10854286